评估ABCG2电荷模型在蛋白质 - 质结合的自由能量计算中
Sudarshan Behera1, Vytautas Gapsys2, Bert L de Groot1
1Computational Biomolecular Dynamics Group, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37077, Germany.
Journal of chemical information and modeling
|October 30, 2025
概括
在评估药物设计的新力场模型时,这项研究发现GAFF2/ABCG2充电模型与GAFF2/AM1-BCC相比,改善了水化自由能量准确性,但没有改善蛋白质-连接体结合自由能量预测.
科学领域:
- 计算化学是一种计算化学.
- 分子建模分子建模
- 药物发现 药物发现
背景情况:
- 准确预测结合的自由能量对于有效的药物设计至关重要.
- 力量场模型是药物发现中的分子模拟的重要工具.
- 评估新的电荷模型,如ABCG2,是必要的,以提高模拟的准确性.
研究的目的:
- 评估ABCG2电荷模型在非平衡化学自由能量模拟中的性能.
- 将GAFF2/ABCG2与GAFF2/AM1-BCC的准确性进行比较,以预测水解和蛋白质-连接体结合的自由能量.
- 为了确定属性特定的力场优化是否会导致相关属性的性能提高.
主要方法:
- 没有使用平衡的化学自由能量模拟.
- 使用了GAFF2/ABCG2和GAFF2/AM1-BCC力场模型.
- 计算和比较了水合的自由能量和蛋白质-配体结合的自由能量.
主要成果:
- 在GAFF2/ABCG2模型中,水合无能量预测的准确性更高.
- 在预测蛋白质 - 配体结合的自由能量方面,GAFF2/ABCG2的表现并没有超过GAFF2/AM1-BCC.
- 这两种充电模型在不同目标上显示了可比的准确性和复合排名.
结论:
- 优化一个特定属性 (例如,无水化能量) 的力场并不能保证相关属性 (例如,结合自由能量) 的性能提高.
- 电荷模型的选择可能会影响自由能量预测的准确性,需要仔细评估.
- 需要对力场开发进行进一步的研究,以提高药物设计中的预测能力.
相关概念视频
02:18The Equilibrium Binding Constant and Binding Strength
14.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.8K
02:18The Equilibrium Binding Constant and Binding Strength
9.9K
9.9K
02:40Ligand Binding Sites
14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
206
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
206
01:49Conserved Binding Sites
5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
00:49Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K